Perceptive Advisors LLC Arcellx, Inc. Transaction History
Perceptive Advisors LLC
- $3.46 Billion
- Q2 2024
A detailed history of Perceptive Advisors LLC transactions in Arcellx, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 3,889,739 shares of ACLX stock, worth $322 Million. This represents 6.21% of its overall portfolio holdings.
Number of Shares
3,889,739
Previous 3,889,739
-0.0%
Holding current value
$322 Million
Previous $215 Million
-0.0%
% of portfolio
6.21%
Previous 6.11%
Shares
9 transactions
Others Institutions Holding ACLX
# of Institutions
173Shares Held
45.6MCall Options Held
53.6KPut Options Held
53.7K-
Paradigm Biocapital Advisors LP New York, NY3.85MShares$318 Million8.59% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$310 Million19.51% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$291 Million0.0% of portfolio
-
Sr One Capital Management, LP2.35MShares$194 Million56.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.3MShares$190 Million0.0% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.63B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...